External control groups are reliable for evaluating experimental gene therapies

FDA approvals, clinical trial design, psychedelic drug policy, compounding pharmacy regulation, and drug scheduling.

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

Application of genomics in clinical diagnosis and care.

Clinical genetics and clinical genomics.